Artificial Intelligence (AI) Validation Study for Polyp Detection
Artificial Intelligence Validation Trial for Polyp Detection: Pilot Study
1 other identifier
interventional
357
1 country
1
Brief Summary
Interventional prospective multicenter study: Polyp detection by an automated endoscopic tool as second observer during routine diagnostic colonoscopy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 18, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 18, 2020
CompletedFirst Submitted
Initial submission to the registry
April 20, 2020
CompletedFirst Posted
Study publicly available on registry
May 7, 2020
CompletedMay 7, 2020
April 1, 2020
6 months
April 20, 2020
May 5, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic accuracy of the novel AI system compared to endoscopic diagnosis as gold standard
Determination of the diagnostic accuracy of the novel AI system as second observer
4 months
Secondary Outcomes (1)
Endoscopist's polyp miss rate as number of extra AI detections
4 months
Study Arms (1)
Intervention arm
EXPERIMENTALColonoscopy with AI
Interventions
Colonoscopy enriched with artificial intelligence tool developed for polyp detection, implemented as a second observer
Eligibility Criteria
You may qualify if:
- \> 18 years
- Diagnostic or screening colonoscopy
- Therapeutic colonoscopy
You may not qualify if:
- Inability to give informed consent by the patient or legal representative
- \< 18 years old
- Any contraindication for colonoscopy or biopsies of the colon
- Uncontrolled coagulopathy
- Confirmed diagnosis of inflammatory bowel disease
- Short bowel or ileostomy
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospitals Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raf Bisschops
UZ Leuven
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 20, 2020
First Posted
May 7, 2020
Study Start
October 30, 2019
Primary Completion
April 18, 2020
Study Completion
April 18, 2020
Last Updated
May 7, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share
We don't share any patient information with other researchers, nor when it's anonymized